Nautilus Biotechnology, Inc. NAUT

0.96 (0.03) (3.03%) as of 25 Sep
Market cap
$126.1M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
84.03 95.87 103.41 131.43

+8 more quarters

Total current assets
87.63 98.83 105.96 134.33
Property, Plant, Equpment (Net)
4.00 3.64 3.46 3.62
Long-Term Investments
45.16 47.51 52.74 37.06
Long-term assets (Other)
1.18 1.18 1.18 1.18
Total non-current assets
75.95 78.95 85.15 66.59
Total Assets
163.58 177.78 191.11 200.92
Accounts Payable
1.10 1.19 0.94 0.89
Accrued Expenses
3.55 3.31 3.18 3.88
Total current liabilities
8.64 8.34 7.95 8.98
Total non-current liabilities
23.83 25.02 26.19 22.79
Total liabilities
32.46 33.36 34.14 31.78
Additional Paid In Capital
492.62 491.21 488.74 487.17
Common Stock (Net)
0.01 0.01 0.01 0.01
Retained Earnings
(361.19) (346.72) (332.02) (318.24)
Common Equity (Total)
131.11 144.42 156.97 169.14
Shareholders Equity (Total)
131.11 144.42 156.97 169.14
Shareholders Equity and Liabilities (Total)
163.58 177.78 191.11 200.92
Shares (Common)
127.23 127.07 126.47 126.31
Shareholders Equity (Tangible)
131.11 144.42 156.97 169.14
Net Debt
(84.03) (95.87) (103.41) (131.43)

Fold the line items

In millions of $ except per-share values · columns are period end dates